会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Glucosamine peptide derivatives, their production and use
    • 葡萄糖胺衍生物,其生产和使用
    • US4369178A
    • 1983-01-18
    • US123401
    • 1980-02-21
    • Yuichi YamamuraIchiro AzumaShigeru Kobayashi
    • Yuichi YamamuraIchiro AzumaShigeru Kobayashi
    • A61K31/70A61K31/7024A61K31/7028A61K38/00A61K39/39A61P35/00A61P37/00A61P37/04C07H13/04C07H13/08C07H15/04C07H15/18C07K1/113C07K9/00A61K37/00C07C103/52
    • C07K9/005
    • Novel glucosamine-peptide derivatives of the formula: ##STR1## wherein m is 0 or 1;n is 0 or an integer of 1 to 9;R is lower alkyl which may be substituted with hydroxyl, or aryl;R.sup.1 is hydrogen or acyl having an acyclic hydrocarbon group, the terminal of which may be substituted with a cyclic hydrocarbon group directly, via a carbonyl group or via an oxygen atom;provided that when R.sup.1 is hydrogen m is 1;R.sup.2 is hydrogen or lower alkyl which may form a ring by connecting its terminal with the .alpha.-nitrogen atom whenn is 0, or hydrogen when n is an integer of 1 to 9;R.sup.3 is hydrogen or lower alkyl;R.sup.4 and R.sup.5 are each hydrogen or lower alkyl which may be substituted with hydroxyl or benzyloxyl;R.sup.6 is hydrogen or lower alkyl;R.sup.7 is alkyl which may be substituted with lower alkoxyl or aralkyl;R.sup.8 and R.sup.9 are each hydrogen, lower alkyl or aralkyl; and(D) and (L) each indicate configurations if their respective carbon atoms are asymmetric;or an acid addition salt thereof, have immunostimulatory activity.
    • 下式的新型葡糖胺肽衍生物:其中m为0或1; n为0或1〜9的整数。 R是可被羟基或芳基取代的低级烷基; R1是氢或具有非环状烃基的酰基,其末端可以被环状烃基直接经由羰基或氧原子取代; 条件是当R1为氢时m为1; R2为氢或低级烷基,当n为0时,可通过将其末端与α-氮原子连接而形成环,或当n为1〜9的整数时为氢; R3是氢或低级烷基; R4和R5各自为氢或可被羟基或苄氧基取代的低级烷基; R6是氢或低级烷基; R7是可被低级烷氧基或芳烷基取代的烷基; R8和R9各自为氢,低级烷基或芳烷基; 和(D)和(L)各自表示构型,如果它们各自的碳原子是不对称的; 或其酸加成盐具有免疫刺激活性。